Literature DB >> 18048462

Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort.

Laura M Reich1, Gerardo Heiss, Lori L Boland, Alan T Hirsch, Kenneth Wu, Aaron R Folsom.   

Abstract

To determine whether elevated levels of hemostatic and inflammatory markers [von Willebrand factor (vWF), fibrinogen, D-dimer, factor VII, factor VIII, PAI-1, tPA, beta-thromboglobulin (beta-TG), CRP, and WBC count] are associated with increased peripheral arterial disease (PAD) prevalence, measured by low ABI, we studied 13,778 participants from the ARIC study in a cross-sectional analysis after adjustment for major cardiovascular risk factors. PAD was positively associated with fibrinogen, vWF, factor VIII, WBC count, D-dimer, beta-TG, and CRP (p for trend <0.05) but not with the other markers. Adjusted odds ratios for the highest versus the lowest quartile of fibrinogen in men and women, respectively, were 3.49 (95% CI 1.68-7.26) and 2.44 (95% CI 1.58-3.77); for vWF 2.36 (95% CI 1.36-4.07) and 1.45 (95% CI 1.00-2.10); for factor VIII 2.31 (95% CI 1.36-3.94) and 1.68 (95% CI 1.14-2.48). In a smaller subset, the sex and risk factor adjusted odds ratio for the highest versus the lowest quartile of D-dimer was 2.70 (95% CI 1.56-4.65), for beta-TG was 1.80 (95% CI 1.12-2.88), and for CRP was 1.57 (95% CI 0.84-2.95). Plasma levels of hemostatic and inflammatory markers are elevated in PAD, suggesting these processes are involved in the pathophysiology of PAD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18048462     DOI: 10.1177/1358863X07082767

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  8 in total

1.  Ethnic differences in ankle brachial index are present in middle-aged individuals without peripheral arterial disease.

Authors:  Siddharth Singh; Kent R Bailey; Iftikhar J Kullo
Journal:  Int J Cardiol       Date:  2011-06-08       Impact factor: 4.164

2.  African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension.

Authors:  M Khaleghi; U Saleem; R D McBane; T H Mosley; I J Kullo
Journal:  J Thromb Haemost       Date:  2008-10-30       Impact factor: 5.824

3.  Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study.

Authors:  R F Gottesman; C Cummiskey; L Chambless; K K Wu; N Aleksic; A R Folsom; A R Sharrett
Journal:  Cerebrovasc Dis       Date:  2009-10-16       Impact factor: 2.762

Review 4.  Novel markers of peripheral arterial disease.

Authors:  Farhan J Khawaja; Iftikhar J Kullo
Journal:  Vasc Med       Date:  2009-11       Impact factor: 3.239

5.  Haemostatic markers are associated with measures of vascular disease in adults with hypertension.

Authors:  M Khaleghi; L A Singletary; V Kondragunta; K R Bailey; S T Turner; T H Mosley; I J Kullo
Journal:  J Hum Hypertens       Date:  2009-01-29       Impact factor: 3.012

6.  Novel risk factors and the prediction of type 2 diabetes in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  L A Raynor; James S Pankow; Bruce B Duncan; Maria I Schmidt; Ron C Hoogeveen; Mark A Pereira; J Hunter Young; Christie M Ballantyne
Journal:  Diabetes Care       Date:  2012-08-28       Impact factor: 19.112

7.  Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief Report.

Authors:  Aeron M Small; Jennifer E Huffman; Derek Klarin; Maria Sabater-Lleal; Julie A Lynch; Themistocles L Assimes; Yan V Sun; Donald Miller; Matthew S Freiberg; Alanna C Morrison; Daniel J Rader; Peter W F Wilson; Kelly Cho; Philip S Tsao; Kyong-Mi Chang; Nicholas L Smith; Christopher J O'Donnell; Paul S de Vries; Scott M Damrauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-08-27       Impact factor: 10.514

8.  The White Blood Cell Count to Mean Platelet Volume Ratio for the Prediction of Chronic Limb-Threatening Ischemia in Lower Extremity Artery Disease.

Authors:  Katharina Guetl; Reinhard Bernd Raggam; Viktoria Muster; Paul Gressenberger; Jovan Vujic; Alexander Avian; Franz Hafner; Martin Wehrschuetz; Marianne Brodmann; Thomas Gary
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.